Pharmacists’ participation in the documentation of medication history in a developing setting: An exploratory assessment with new criteria

  • Kazeem B. Yusuff
  • Fola Tayo
  • Bolajoko A. Aina
Keywords: Medical Records, Pharmacists, Nigeria

Abstract

Objective: To assess the impact of pharmacists’ participation on the frequency and depth of medication history information documented in a developing setting like Nigeria

Method: The study consisted of two phases. The first phase was a baseline cross-sectional assessment of the frequency and depth of medication history information documented by physicians in case notes of systematic samples of 900 patients that were stratified over 9 Medical outpatients Units at a premier teaching hospital in south western Nigeria. The second phase was an exploratory study involving 10 pharmacists who conducted cross-sectional medication history interview for 324 randomly selected patients.

Results: 49.2% of patients, whose medication history were documented at the baseline, by physicians, were males; while 50.3% of patient interviewed by pharmacists were male. Mean age (SD) of males and females whose medication histories were documented by physicians and pharmacists were 43.2 (SD=18.6), 43.1 (SD=17.9) years and 51.5 (SD=17.6), 52.1 (SD=17.4) years respectively. The frequency of medication history information documented by pharmacists was significantly higher for twelve of the thirteen medication history components (P < 0.0001). These include prescription medicines; over the counter medicines; source of medicines; adverse drug reactions; allergy to drugs, allergy to foods, allergy to chemicals; patient adherence; alcohol use; cigarette smoking; dietary restrictions and herbal medicine use. The depth of medication history information acquired and documented by pharmacist was significantly better for all the thirteen medication history components (P<0.0001).

Conclusion: Pharmacists’ participation resulted in significant increase in frequency and depth of medication history information documented in a developing setting like Nigeria. The new medication history evaluation criteria proved useful in assessing the impact of pharmacists’ participation.

Downloads

Download data is not yet available.

References

1. Covington TR. Interviewing and advising patients. In Francke DE, Whitney HAK Jr. eds. Perspectives in Clinical Pharmacy, 1st edition, Illinois: Hamilton 1972.

2. Tietzie K. Clinical skills for pharmacists, a patient-focused approach. Mosby-year book inc. St Loius, Missouri. USA, 1997;39-40.

3. Cohen J, Wilson C, Ward F. Improve drug history taking. Pharmacy in Practice.1998;1:13-16.

4. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape L, Bates DW. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-1564.

5. Wilcock M, Lawrence J. Is there a role for community pharmacists in identifying discrepancies in medication histories for patients admitted to hospital? Pharm J. 2004;272:253-256.

6. Beers MH, Munekata M, Storrie M. The accuracy of medication histories in the hospital medical records of elderly persons. J Am Geriatr Soc. 1990;38:1183-1187.

7. Batty GM, Oborne CA, Swift CG, Jackson SH. The use of over-the-counter medication by elderly medical inpatients. Postgrad Med J. 1997;73(865):720-722.

8. Bedell SE, Jabbour S, Goldberg R, Glaser H, Gobble S, Young-Xu Y, Graboys TB, Ravid S. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med. 2000;160:2129-2134.

9. Yusuff KB, Awotunde M. The frequency of drug history documentation in an institutionalized tertiary care setting in Nigeria. J Pharm Pharm Sci. 2005; 8(2):140-145.

10. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Can Med Assoc J. 2005;173(5):510-515.

11. Gleason KM, Groszek JM, Sullivan C, Rooney D, Barnard C, Noskin GA. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health-Syst Pharm. 2004;61:1689-1695.

12. Massey C. An evaluation of the benefits of pharmacist-acquired drug histories. Proc Guild Hosp Pharm.1987;25:80-81.

13. Montpetit LM, Roy MT. Evaluation of a patient-completed versus health professional-conducted medication history. Drug Intell Clin Pharm. 1988;16:592-595.

14. Hocking G, Kalyanaraman R, deMello WF. Better drug history taking: an assessment of the drug mnemonic. J R Soc Med. 1998;91:305-306.

15. Nester TM, Hale LS. Effectiveness of a pharmacist-acquired medication history in promoting patient safety. Am J Health-Syst Pharm. 2002;59(22):2221-2225.

16. Gurwich EL. Comparison of medication histories acquired by pharmacists and physicians. Am J Hosp Pharm.1983;40:1541-1542.

17. Akwagyriam I, Goodyer LI, Harding L, Khakoo S, Millington H. Drug history taking and the identification of related problems in an accident and emergency department. J Accid Emerg Med. 1996;13:166-168.

18. McRobbie D, Bednall R, West T. Assessing the impact of re-engineering of pharmacy services to general medical wards. Pharm J. 2003;270:342-345.

19. Eniojukan JF, Aina BA, Tijani MM. Drug distribution network in Nigeria Nig Quart J Hosp Med. 1997;7:384-389.

20. Erhun WO, Babalola OO, Erhun MO. Drug regulation and control in Nigeria: The challenge of counterfeit drugs. J Health Pop Develop Countries. 2001;4(2):23-34.

21. Taylor RB, Sharkoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, Reid RG, Kolawole JA. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet. 2001;357(9272):1933-1936.

22. Ositelu A. Ocular drug abuse in Lagos, Nigeria. Acta Opthalmologica 1989;67:396-400.

23. Erhun WO, Agunedu CO. Procurement and sale of drugs in a market-place. Nig J Pharm. 1995;26:30-32.

24. Ajayi IO, Falade CO. Pre-hospital treatment of febrile illness in children attending the General Outpatient Clinic, University College Hospital, Ibadan, Nigeria. Afr J Med Med Sci. 2006;35:85-91.

25. Dunne J. Deadly medicines: the cost of substandard drugs. Medicine Digest 1997;23:5-7.

26. Maponga C, Odari C. The quality of antimalarial; A study in selected African countries. World Health Organization. Geneva. WHO/EDM/PAR. 2003;4:1-54.

27. Alubo SA. Drugging the people: pills, profits and underdevelopment in Nigeria. Studies in Third World Societies. 1985;24:89-113.

28. Bouwmeester M, Laberge N, Bussieres J, Lebel D, Bailey B, Harel F. Program to remove incorrect allergy documentation in pediatrics medical records. Am J Health-Syst Pharm. 2001;58:1722-1727.

29. Geibig CB, Mansur JM, Medema PG. Pharmacy-controlled documentation of drug allergies. Am J Hosp Pharm. 1991;48:260-264.

30. Tripp DM, Brown GR. Pharmacist assessment of drug allergies. Am J Hosp Pharm. 1993;50:95-98.

31. Bieszk N. Detection of medication non-adherence through review of pharmacy claims data. Am J Health-Syst Pharm. 2003;60(4):360-366.

32. Badowski SA, Rosenbloom D, Dawson PH. Clinical importance of pharmacist-obtained medication histories using a validated questionnaire. Am J Hosp Pharm. 1984;41:731-732.

33. Cradock JC, Whitefield GR, Menzie JW. Post-admission drug allergy histories recorded by pharmacists. Am J Hosp Pharm. 1972;29:250-252.
Published
2010-06-19
Section
Original Research